Skip to main content

Research may lead to better understanding of injured spinal cord therapy

Treating spinal cord injuries with a mixture of immature spinal cord neurons and stem cells, also known as "designer neurons," has led to some improved, though limited, results in some patients. Success depends on the new cells forming working connections with the surviving nerve cells in the spinal cord.

Jeff Gamble

Currently, researchers can test the effectiveness of stem cell transplants on spinal cord injuries by measuring gross motor skills and recovery of the senses, as well as other assessments to determine if the transplanted designer neurons are growing and forming new synapses. However, it is extremely difficult to measure the functionality of connections within the transplanted neural networks.

Jeffrey Gamble, a doctoral student in the lab of Dennis Barbour, MD, PhD, associate professor of biomedical engineering, is developing a new cell culture platform that will allow biomedical engineers and spinal cord injury researchers to better evaluate communication and interactions between the designer neurons and surviving native spinal cord neurons. This platform will give researchers some insight into whether the designer neurons have properties conducive to effective stem cell therapy.

"When neurons are injected into the site of injury, they form network connections among themselves and to existing cells to restore function," Gamble says. "This project focuses on connectivity, how these stem cell-derived neurons talk to each other and if certain populations of neurons talk to each other better than others."

Gamble will be doing the research with funding from a two-year, nearly $250,000 grant from the Spinal Cord Injuries Research Program at the University of Missouri recently awarded to Barbour.

Gamble says different types of neurons may be better candidates for transplanting in a spinal cord injury than others. His doctoral thesis project is looking at V2a interneurons, which have been implicated as potential transplant candidates because of their ability to excite other neurons and to communicate over long distances in the spinal cord.

The School of Engineering & Applied Science at Washington University in St. Louis focuses intellectual efforts through a new convergence paradigm and builds on strengths, particularly as applied to medicine and health, energy and environment, entrepreneurship and security. With 88 tenured/tenure-track and 40 additional full-time faculty, 1,300 undergraduate students, more than 900 graduate students and more than 23,000 alumni, we are working to leverage our partnerships with academic and industry partners — across disciplines and across the world — to contribute to solving the greatest global challenges of the 21st century.

Improving Medicine & Health

Doctoral student Jeffrey Gamble is developing a new cell culture platform that will allow biomedical engineers to better evaluate communication between immature spinal cord neurons and surviving neurons after a spinal cord injury.